617
Views
7
CrossRef citations to date
0
Altmetric
Original

Socket wall addition device in the treatment of recurrent hip prosthesis dislocation : Good outcome in 12 patients followed for 4.5 (1–9) years

, &
Pages 87-91 | Received 14 Dec 2004, Accepted 13 Jun 2005, Published online: 08 Jul 2009
 

Abstract

Background Recurrent dislocation in total hip replacement is difficult to treat and causes severe morbidity.

Patients and methods 12 patients suffering dislocations were reoperated with a socket wall addition device (anti-luxation ring) for the Lubinus SPII prosthesis, and were followed up after a mean of 4.5 (1–9) years with regard to redislocation, function and radiographic loos-ening.

Results 1 of the patients suffered a redislocation after almost 7 years of use. There was no loosening during the follow-up time. A Harris hip score of 87 (60–100), a health-related quality of life (EQ-5D) index of 0.8 (0.6–1.0) and total range of motion of 145° (125–165) indicate that the patients had a level of function comparable to that of age-matched hip surgery patients with no com-plications.

Interpretation The anti-luxation ring shows promising mid-term results and seems to provide an alternative to more extensive revision surgery for selected patients. ▪

Author contributions

AE, JM clinical examination, radiographic analyzing and design of study. OS design of study.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.